<DOC>
	<DOCNO>NCT02165020</DOCNO>
	<brief_summary>The present Phase II study aim assess rate late rectal toxicity grade ≥ 2 hypofractionated radiotherapy prostate cancer 62 Gy 20 fraction 3.1 Gy injection hyaluronic acid ( HA ) space rectum prostate . Thirty-six patient low- intermediate-risk prostate cancer accord D'Amico classification include present protocol . The main characteristic study patient benefit reduction treatment duration 40 20 fraction , due hypofractionated irradiation , injection 3 10 cc hyaluronic acid perirectal fat rectum prostate .</brief_summary>
	<brief_title>Hyaluronic Acid Hypofractionated Prostate Radiotherapy</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>age superior equal 18 year inferior 80 year . patient low intermediaterisk prostate cancer , accord D'Amico classification , exclusive irradiation . prostate cancer histologically proven . life expectancy superior 10 year . Karnofsky performance status ≥ 60 % ( performance status ECOG 02 ) . patient beneficiary social security system insurance ( order n° 2006477 April 26th 2006 ) . sign consent form . age inferior 18 year ≥ 80 year ; history rectal surgery ; patient ca n't cooperate treatment ; history pelvic irradiation ; history inflammatory bowel disorder ulcerative colitis Crohn 's disease ; current neoplasia history neoplasia date less 5 month , except basalcell carcinoma ; patient treat antineoplastic antiangiogenic treatment use rheumatology may include methotrexate ( order radiosensitizing effect ) ; patient receive anticoagulant treatment PLAVIX ; undergo study may interfere present study ; patient legal protection measure .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Prostate</keyword>
	<keyword>Hypofractionated radiotherapy</keyword>
	<keyword>Hyaluronic acid</keyword>
	<keyword>Spacer</keyword>
	<keyword>Rectum toxicity</keyword>
	<keyword>Rectal toxicity hypofractionated irradiation injection hyaluronic acid patient low- intermediate-risk Prostate Cancer</keyword>
</DOC>